Review Questions Tamiflu's Effectiveness:

Links shared publicly online about this topic.

  • 1,545
    total visits

Review Questions Tamiflu's Effectiveness:

health.msn.com

Review Questions Tamiflu's Effectiveness:

View full resource at health.msn.com

Tags: Flu Medication, Tamiflu

  • Share

Most Recently Shared on December 8, 2009 at 10:55 pm By:

msnhealthnews msn

Review Questions Tamiflu's Effectiveness: http://bit.ly/8I0QUr

2 years ago...

Coronary heart disease - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 12:18 pm By:

dankeithhealth screenings. We take the best of traditional health promotion services and combine them with technology, clinical expertise, on-site programming, data input and on-going support services.  Dan Keith, Vice President" /> It Starts With Me Health Promotion Programs Health Executive and Active Health Library

Irritable bowel syndrome - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on April 4, 2012 at 12:40 pm By:

Crohn's disease - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:51 am By:

Ulcerative colitis - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:50 am By:

Are Weight-Loss Supplements Effective? Study Says Most Aren't - Shape Magazine

shape.com — “Dr. Melinda Manore, professor of nutrition at Oregon State University, has been doing energy-balance research for 25 years in active and sedentary individuals. The one questions she always gets? “What supplements can I buy for weight loss?” So, like any good researcher she dived into the research, reviewing the evidence surrounding hundreds of weight-loss supplements.View full resource at shape.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 6:30 pm By:

robertgrantmd Robert T Grant MD Physician, Doctor, Surgeon, and Plastic Surgeon

Are Weight-Loss Supplements Effective? Study Says Most Aren't... http://t.co/pLQqmMGh

4 weeks ago...

FDA staff question benefit of Merck-Ariad drug - Yahoo! News

news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a sarcoma treatment from Merck & Co Inc and Ariad Pharmaceuticals Inc kept tumors at bay for long enough, given the drug's serious side effects. The drug, called Taltorvic, is meant as a maintenance therapy for people with soft tissue or bone sarcoma who have had four successful rounds of chemotherapy. U.S. Food and Drug Administration staff found the drug stopped cancer from spreading two weeks longer than a placeboView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 4:19 pm By:

BoneCancer_OW Bone Cancer OW OW Health

FDA staff question benefit of Merck-Ariad drug: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a ... http://t.co/ctXdTin7

1 month ago...

Sleeping pills linked to death risk - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 9:43 pm By:

Ectodermal dysplasia - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 8, 2012 at 8:41 pm By:

nataliehodgePersonal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium in '09 and has been named by Brian Dolan of Mobi Heath News as "The First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.

Dr. Hodge's special interests in pediatrics include nutrition, prevention and the potential for the internet to strengthen physician patient relationships. Dr. Hodge is a member of the Health care Information and Management Systems Society (HIMSS), a Fellow of the Academy of Pediatrics' Quality and Innovation Network, and a founding member of the Society for Participatory Medicine. Participatory Medicine is an emerging group of engaged patients and physicians who believe that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Doctor, Pediatrician, Physician, and Active Health Library

Ectodermal dysplasia - PubMed Health http://t.co/vHOOEPRH Interesting patient today

1 month ago...

Kawasaki disease - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on February 21, 2012 at 5:30 pm By:

ravimohanv Vel Ravimohan Physician, Doctor, ObGyn Physician, and Surgeon

Reading about : Kawasaki disease Mucocutaneous lymph node syndrome; Infantile polyarteritis http://t.co/MfpxkjyU

2 months ago...

Medical News: New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today

medpagetoday.com — “A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drugView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 18, 2012 at 12:18 pm By:

greggalexMadison Pediatrics in London, Ohio. Dr. Alexander has long promoted the use of a variety technologies for advancing healthcare. He is the current director of the Pediatric Office of the Future for the American Academy of Pediatrics and also serves on the AAP’s Council on Clinical Information Technology Executive Committee as well as the Project Advisory Committee for the Child Health Informatics Center. 

An original member of the Ohio Health Information Partnership’s Regional Extension Center Committee, he was elected to OHIP’s primary Board of Directors in February, 2011. He further promotes the value of advanced healthcare technology in his role on the Professional Advisory Council of ModernMedicine.com and as a regular blogger for HIStalkPractice.com." /> Gregg Alexander, DO Health Executive, Physician, Active Health Library, Doctor, and Pediatrician

New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today - http://t.co/7MCdPafg from @medpagetoday

3 months ago...

Medical News: New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today

medpagetoday.com — “A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drugView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 18, 2012 at 1:02 am By:

MedicalFeed MedicalFeed Health News Feed

New Analysis Challenges Tamiflu Efficacy (CME/CE): (MedPage Today) -- A new review of the… http://t.co/mtuGqFSw

3 months ago...

New Questions Raised About Tamiflu's Effectiveness - NYTimes.com

prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.View full resource at prescriptions.blogs.nytimes.com

  • View Related
  • Share

Most Recently Shared on January 18, 2012 at 12:31 am By:

Health_CK Catherine K Health Advocate

Prescriptions Blog: New Questions Raised About Tamiflu's Effectiveness: A new study by the Cochrane Collaboratio... http://t.co/USIZmcHW

3 months ago...

New Questions Raised About Tamiflu's Effectiveness - NYTimes.com

prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.View full resource at prescriptions.blogs.nytimes.com

  • View Related
  • Share

Most Recently Shared on January 18, 2012 at 12:06 am By:

NYTPrescription NYT Prescriptions

New Questions Raised About Tamiflu's Effectiveness http://t.co/uU93MpsJ

3 months ago...

Pulmonary hypertension - PubMed Health

ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on January 15, 2012 at 10:51 pm By:

DrRichardBesser Richard Besser Pediatrician, Health Communicator, Physician, and Doctor

What do you need to know? Heres some info: http://t.co/T6YpD3W2 RT @smortie11: @DrRichardBesser Really need info re pulmonary hypertension!

3 months ago...

Advertisement